Breakthrough by the Numbers

With more than 18 years of experience, Mike Gordon has held several senior-level global leadership roles of increasing scope and responsibility, mainly within technology-focused organizations. Mr. Gordon’s most recent corporate leadership role was with Callcredit Information Group as Chief Executive Officer, where he oversaw a successful transformation of the business and an eventual sale to Transunion. Mr. Gordon also currently serves on the board of directors of three technology companies, Fintech, Hometrack and Constructonline.

Prior to Callcredit Information, Mr. Gordon served as FICO’s Executive Vice President of Sales, Services, and Marketing, after serving in various roles of increasing responsibility across the company’s banking, insurance, retail, health care and pharmaceutical markets. Before joining FICO in 2005, Mr. Gordon spent more than 13 years in the financial services industry. As a vice president at Capgemini (formerly Ernst & Young Consulting LLP) his competency was in providing strategic and operational solutions to banking and insurance providers, leading the Insurance Center of Excellence and Solutions.

Mr. Gordon received a BS in Industrial Engineering / Operations Research from Northwestern University and an MBA in Finance and Business Economics from The University of Chicago Graduate School of Business.

Kelly is a recognized industry leader in RIM and IDMP with over 20 years experience in the pharmaceutical industry, the last 11 focused on Regulatory Affairs. She has led both IT and RIM/Reg Ops organizations in several companies and has overseen implementation of large-scale global systems and processes. Kelly is passionate about the possibilities for pharma companies to improve productivity and compliance through process-focused management of critical data. She is an industry leader on the EMA SPOR Task Force and its PMS subteam and is also involved in ISO TC/215.

Pat Jenakanandhini serves as ArisGlobal’s Chief Product Officer, where he oversees all product strategy and management functions. Prior to ArisGlobal, Pat served as Senior Vice President of Products at Accruent and Chief Technology Officer at BlueCielo, acquiring several years of experience building and delivering SaaS products including serving. During his tenure at Accruent, the company completed 5 acquisitions, built a strong product strategy driving growth that eventually led to Accruent being acquired by Fortive, a large publicly listed company. At BlueCielo, Pat was responsible for driving the transformation of the product, the business and the culture of product & engineering teams to focusing on SaaS. Pat is passionate about building great software that delights users, solves real business problems and provides a superior user experience. Pat lives just outside Boston, MA with his wife, 2 kids and dog. Pat loves building things, home automation, playing video games, and traveling the world. He has an MBA in Finance and dual degrees in Computer Science and Process & Piping Design.

Claudia Lehmann serves as Vice President of Patient Safety & Pharmacovigilance Operations & Systems for Boehringer Ingelheim. Prior to this role, she was leading Biostatistics and Data Management Europe within Boehringer Ingelheim, Claudia is a member of the ICH MedDRA Management Committee and an SME on the Eudravigilance EWG.

Claudia has been trained in medical information management at an affiliation of the University of Ulm, Germany

Jennifer is Senior Director of the Global Safety Systems team within the World Wide Patient safety organization at Bristol Myers Squibb. In her 18 year tenure with BMS, she has led two Global Safety Database implementations and built the dedicated team that provides stewardship of the organization’s systems, while actively driving system roadmaps.

Jennifer is passionate about the possibilities of safety organizations improving their business value, quality, and ultimately empowering more effective and efficient patient safety through standardization of systems and process.
Prior to joining the Pharmaceutical industry, Jennifer worked as an Oncology nurse for Princeton Medical Center.

Dr. Scott has been appointed the Chairman of the Advisory Board, in addition to serving as a member of ArisGlobal’s Board of Directors. Dr. Scott joins the board with over 30 years of experience in the life sciences industry, most recently serving as the Chief Medical Officer and Head of Development at AbbVie, where he led a team of more than 4,000 individuals across 52 countries.

Marina is a passionate, experienced, and motivated professional with over 13 years of experience in the pharmaceutical industry, particularly safety surveillance. Her expertise and experience in pharmacovigilance and quality activities, combined with her innovative thinking style and enthusiasm has helped many companies and departments propel through their transformation journeys. Her expertise are in process optimization and ensuring standards and compliance within the GVP guidelines. Marina holds a master’s degree in pharmaceutical sciences from Greenwich University and a bachelor’s degree in medical biochemistry from Brunel University.

Gary is Managing Director & Co-Founder of CorrIT and creator of the SPORIFY web application. Gary holds a BSc (Hons) in Computer Science and has over 18 years industry and consultancy experience. Since the launch of SPORIFY in 2017, CorrIT have assisted many organisations and regulators with their implementation and integration of SPOR Master Data Services as they move towards IDMP in Europe and has a sharp focus on a data first approach with global reference data management and interoperability of systems. Gary is a member of the SPOR Key Use Group and IDMP inter-association group.

Kristy Wort serves as the Vice President of Clinical Operations for Total Diversity Clinical Trial Management (TOTAL). In this role, she has strategic oversight across clinical operations.

Before joining TOTAL in 2017, Wort started her career at a research site as a Recruitment Manager and eventually moved into a position as a Global Project Manager. She has more than 20 years of experience in operational delivery in clinical trials, including global regulations, cultures, and customs relevant to the successful implementation of projects in the clinical trial industry.

Wort has a vast array of therapeutic experience, including women’s health, dermatology, hematology/oncology, rare disease, nervous system and endocrine/metabolic just to name a few.

Kristy earned a Bachelor’s degree in marketing from the Intercontinental University in Atlanta. She holds a white belt certification in risk-based management.